Clinical trial
Comparison of the Efficacy of Hemoadsorption Combined With Hemodialysis of Different Treatment Durations in Clearing Protein-Bound Uremic Toxins: A Randomized Crossover Controlled Trial
NCT07111260 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Efficacy of Hemoadsorption Combined With Hemodialysis of Different Treatment Durations in Clearing Protein-Bound Uremic Toxins: A Randomized Crossover Controlled Trial
- Lead sponsor
- Peking University People's Hospital
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 1, 2025
- Completion date
- May 31, 2026
- Enrollment
- 34 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease on dialysis